The amyloid fibrils of Alzheimer's neuritic plaques and cerebral blood vessels are mainly composed of aggregated forms of a 39 to 44 amino acids peptide, named amyloid beta (A beta). A similar although soluble form of A beta (sA beta) has been identified in plasma, cerebrospinal fluid and cell culture supernatants, indicating that it is produced under physiologic conditions. We report here that sA beta in normal human plasma is associated with lipoprotein particles, in particular to the HDL(3) and VHDL fractions where it is complexed to ApoJ and, to a lesser extent, to ApoAl. This was assessed by immunoprecipitation experiments of purified plasma lipoproteins and lipoprotein-depleted plasma and confirmed by means of amino acid sequence analysis. Moreover, biotinylated synthetic peptide A beta(1-40) was traced in normal human plasma in in vitro experiments. As in the case of sA beta, biotinylated A beta(1-40) was specifically recovered in the HDL(3) and VHDL fractions. This data together with the previous demonstration that A beta(1-40) is taken up into the brain via a specific mechanism and possibly as an A beta(1-40)-ApoJ complex indicate a role for HDL(3)- and VHDL-containing ApoJ in the transport of the peptide in circulation and suggest their involvement in the delivery of sA beta across the blood-brain barrier. (C) 1994 Academic Press, Inc.